MINNEAPOLIS-The National Marrow Donor Program (NMDP) has reached a new milestone: 10,000 unrelated donor transplants. “At our 10-year anniversary in 1997, we celebrated 6,000 unrelated transplants, but in just 3 years, we have increased that number to 10,000,” Dr. Dennis Confer, chief medical office, said in a news release. The program, which has a volunteer registry of more than 4 million potential donors, facilitates transplants for more than 120 patients each month, he said.
MINNEAPOLISThe National Marrow Donor Program (NMDP) has reached a new milestone: 10,000 unrelated donor transplants. At our 10-year anniversary in 1997, we celebrated 6,000 unrelated transplants, but in just 3 years, we have increased that number to 10,000, Dr. Dennis Confer, chief medical office, said in a news release. The program, which has a volunteer registry of more than 4 million potential donors, facilitates transplants for more than 120 patients each month, he said.
The NMDP has scheduled a month-long calendar of events in November for Marrow Awareness Month. The events will culminate in a tribute at the World Trade Center, New York, to celebrate both the 10,000th transplant milestone and the legacy of the late Admiral E.R. Zumwalt Jr., USN (Ret), a founding father of the NMDP and The Marrow Foundation.
For information on how to become a donor, call 1-800-MARROW-2 or visit online at www.marrow.org.
Addition of Capivasertib to Paclitaxel Fails to Improve OS in Metastatic TNBC
September 13th 2024The phase 3 CAPItello-290 trial of capivasertib plus paclitaxel did not meet its primary end point of improved overall survival in the frontline setting of metastatic triple-negative breast cancer.
Addition of Capivasertib to Paclitaxel Fails to Improve OS in Metastatic TNBC
September 13th 2024The phase 3 CAPItello-290 trial of capivasertib plus paclitaxel did not meet its primary end point of improved overall survival in the frontline setting of metastatic triple-negative breast cancer.
2 Commerce Drive
Cranbury, NJ 08512